April 19, 2024 11:24 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Maldives opposition demands President Muizzu's impeachment over leaked reports alleging corruption by him | AAP claims conspiracy to kill Arvind Kejriwal after mango eating row | India successfully tests Indigenous Technology Subsonic Cruise Missile | Telangana missionary school vandalised after students questioned over saffron attire | Shilpa Shetty's husband Raj Kundra's properties attached by ED in Bitcoin scam
CCI approves merger of Serum Institute subsidiaries Biocon Biologics and CTPL

CCI approves merger of Serum Institute subsidiaries Biocon Biologics and CTPL

New Delhi: The Competition Commission of India (CCI) has approved the merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for the acquisition of approximately 15 percent equity shareholding of Biocon Biologics by Serum Institute Life Sciences.